Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB

The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway

(2015) Hye Jung Ihn et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

17-Hydroxy-jolkinolide A inhibits osteoclast differentiation through suppressing the activation of NF-κB and MAPKs

(2015) Yingjian Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Calycosin orchestrates the functions of Danggui Buxue Tang, a Chinese herbal decoction composing of Astragali Radix and Angelica Sinensis Radix: An evaluation by using calycosin-knock out herbal extract

(2015) Amy Guo-wei Gong et al.   JOURNAL OF ETHNOPHARMACOLOGY

Calycosin induces apoptosis in human ovarian cancer SKOV3 cells by activating caspases and Bcl-2 family proteins

(2015) Yan Zhou et al.   TUMOR BIOLOGY

Calycosin induces apoptosis by the regulation of ERβ/miR-17 signaling pathway in human colorectal cancer cells

(2015) Jian Chen et al.   Food & Function

Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations

(2014) Rubiao Qiu et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

9-Hydroxy-6,7-dimethoxydalbergiquinol inhibits osteoclast differentiation through down-regulation of Akt, c-Fos and NFATc1

(2014) Ju-Young Kim et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Genistein Inhibits Osteoclastic Differentiation of RAW 264.7 Cells via Regulation of ROS Production and Scavenging

(2014) Sang-Hyun Lee et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Formononetin Attenuates Osteoclastogenesis via Suppressing the RANKL-Induced Activation of NF-κB, c-Fos, and Nuclear Factor of Activated T-Cells Cytoplasmic 1 Signaling Pathway

(2014) Jeong-Eun Huh et al.   JOURNAL OF NATURAL PRODUCTS

Screening Active Components from Yu-Ping-Feng-San for Regulating Initiative Key Factors in Allergic Sensitization

(2014) Dandan Shen et al.   PLoS One

Effects and mechanisms of 8-prenylnaringenin on osteoblast MC3T3-E1 and osteoclast-like cells RAW264.7

(2014) Dan Luo et al.   Food Science & Nutrition

Activation of adenosine A2Areceptor reduces osteoclast formation via PKA- and ERK1/2-mediated suppression of NFκB nuclear translocation

(2013) Aránzazu Mediero et al.   BRITISH JOURNAL OF PHARMACOLOGY

Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells

(2011) Mehdi Shakibaei et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration

(2011) Youhua Xu et al.   JOURNAL OF ETHNOPHARMACOLOGY

Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressingc-fos-inducedNFATc1expression

(2010) Sahar Karieb et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease

(2010) Mikihito Kajiya et al.   Journal of Oral Microbiology

The  -Isoform of p38 MAPK Specifically Regulates Arthritic Bone Loss

(2009) C. Bohm et al.   JOURNAL OF IMMUNOLOGY

Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway

(2008) T. Akiyama et al.   MOLECULAR CANCER THERAPEUTICS